Skip to main content
Top
Published in: Annals of Nuclear Medicine 7/2012

01-08-2012 | Technical note

New knowledge about the bremsstrahlung image of strontium-89 with the scintillation camera

Authors: Hiroto Narita, Kiyoshi Hirase, Mayuki Uchiyama, Masahiro Fukushi

Published in: Annals of Nuclear Medicine | Issue 7/2012

Login to get access

Abstract

Objective

Strontium-89 (89Sr) chloride has been used to treat metastases in bone. A method to visualize the distribution of 89Sr chloride with a scintillation camera was developed in 1996. Studies using bremsstrahlung imaging have shown that 89Sr accumulates in bone and that the bremsstrahlung generated from biological tissue surrounding bone does not exceed 30 keV. However, it was not clear how low-energy bremsstrahlung from bone can produce peak energy levels of around 75 keV. We speculate that a different (unidentified) factor is involved.

Methods

The energy spectrum of an 89Sr source was acquired with a scintillation camera with or without a low-to-medium-energy general-purpose collimator. The energy window was set at 20–650 keV for 4 windows. A 50-mm thick acrylic block was placed between the scintillation camera and the 89Sr source to exclude the effects of bremsstrahlung. The energy spectrum of 89Sr covered with lead was acquired using the scintillation camera without a collimator.

Results

With the collimator the energy spectrum curve was similar to that without the 50 mm of acrylic. The energy spectrum curve showed peaks at about 75, 170, and 520 keV. Without the collimator the energy spectrum showed a similar curve but no peak at 75 keV peak. The curve was similar to that obtained with the scintillation camera and the collimator; however, the curve obtained when the 89Sr source had been placed in a lead container was similar to that obtained when the source was unshielded, and the collimator was not attached to the scintillation camera.

Conclusion

If bremsstrahlung of 89Sr produces an image, a low-energy spectrum region should decrease when acrylic is placed between the 89Sr source and the scintillation camera. However, similar curves were obtained both with the acrylic in place and without the acrylic. Therefore, we believe that the radiation detected by the scintillation camera was not bremsstrahlung due to the beta rays of 89Sr. Most 89Sr preparations are contaminated by 85Sr, and most of the gamma ray energy of 85Sr is 514 keV. The scintillation camera detected the characteristic X-ray energy of about 75 keV from the materials of the collimator (lead and others) through interaction with the gamma rays of 85Sr.
Literature
1.
go back to reference Narita H, Uchiyama M, Ooshita T, Hirase K, Makino M, Mori Y, et al. Imaging of strontium-89 uptake with bremsstrahlung using NaI scintillation camera. Kaku Igaku. 1996;33(11):1207–12.PubMed Narita H, Uchiyama M, Ooshita T, Hirase K, Makino M, Mori Y, et al. Imaging of strontium-89 uptake with bremsstrahlung using NaI scintillation camera. Kaku Igaku. 1996;33(11):1207–12.PubMed
2.
go back to reference Uchiyama M, Narita H, Makino M, Sekine H, Mori Y, Fukumitsu N, et al. Strontium-89 therapy and imaging with bremsstrahlung in bone metastases. Clin Nucl Med. 1997;22(9):605–9.PubMedCrossRef Uchiyama M, Narita H, Makino M, Sekine H, Mori Y, Fukumitsu N, et al. Strontium-89 therapy and imaging with bremsstrahlung in bone metastases. Clin Nucl Med. 1997;22(9):605–9.PubMedCrossRef
3.
go back to reference Cipriani C, Atzei G, Argirò G, Boemi S, Shukla S, Rossi G, et al. Gamma camera imaging of osseous metastatic lesions by strontium-89 bremsstrahlung. Eur J Nucl Med. 1997;24(11):1356–61.PubMedCrossRef Cipriani C, Atzei G, Argirò G, Boemi S, Shukla S, Rossi G, et al. Gamma camera imaging of osseous metastatic lesions by strontium-89 bremsstrahlung. Eur J Nucl Med. 1997;24(11):1356–61.PubMedCrossRef
4.
go back to reference Baziotis N, Yakoumakis E, Zissimopoulos A, Geronicola-Trapali X, Malamitsi J, Proukakis C. Strontium-89 chloride in the treatment of bone metastases from breast cancer. Oncology. 1998;55(5):377–81.PubMedCrossRef Baziotis N, Yakoumakis E, Zissimopoulos A, Geronicola-Trapali X, Malamitsi J, Proukakis C. Strontium-89 chloride in the treatment of bone metastases from breast cancer. Oncology. 1998;55(5):377–81.PubMedCrossRef
5.
go back to reference Ota S, Toyama H, Uno M, Kato M, Ishiguro M, Natsume T, et al. A trial of 89Sr bremsstrahlung SPECT. Kaku Igaku. 2011;48(2):101–7.PubMed Ota S, Toyama H, Uno M, Kato M, Ishiguro M, Natsume T, et al. A trial of 89Sr bremsstrahlung SPECT. Kaku Igaku. 2011;48(2):101–7.PubMed
6.
go back to reference Oda H, Hara H, Ueda O, Kawamata H, Sakai H, Katou Y, et al. Underlying examination in the imaging of 89Sr bremsstrahlung radiation. Nihon Hoshasen Gijutsu Gakkai Zasshi. 2010;66(7):764–73.PubMedCrossRef Oda H, Hara H, Ueda O, Kawamata H, Sakai H, Katou Y, et al. Underlying examination in the imaging of 89Sr bremsstrahlung radiation. Nihon Hoshasen Gijutsu Gakkai Zasshi. 2010;66(7):764–73.PubMedCrossRef
7.
go back to reference ICRP Publication 23. Report of the Task Group on reference man. Pergamon Press, Oxford; 1974, p. 327. ICRP Publication 23. Report of the Task Group on reference man. Pergamon Press, Oxford; 1974, p. 327.
8.
go back to reference Yamada T, Nakamura Y, Sato Y, Yunoki A, Hino Y. Measurement of strontium-89 solution sources for bone pain palliation using re-entrant ionization chambers. Radioisotopes. 2007;56:93–101.CrossRef Yamada T, Nakamura Y, Sato Y, Yunoki A, Hino Y. Measurement of strontium-89 solution sources for bone pain palliation using re-entrant ionization chambers. Radioisotopes. 2007;56:93–101.CrossRef
10.
go back to reference Breen SL, Powe JE, Poter AT. Dose estimation in strontium-89 radiotherapy of metastatic prostatic carcinoma. J Nucl Med. 1992;33:1316–23.PubMed Breen SL, Powe JE, Poter AT. Dose estimation in strontium-89 radiotherapy of metastatic prostatic carcinoma. J Nucl Med. 1992;33:1316–23.PubMed
11.
go back to reference Blake GM, Zivanovic MA, McEwan AJ, Condon BR, Ackery DM. Strontium-89 therapy: strontium kinetics and dosimetry in two patients treated for metastasising osteosarcoma. Br J Radiol. 1987;60:253–9.PubMedCrossRef Blake GM, Zivanovic MA, McEwan AJ, Condon BR, Ackery DM. Strontium-89 therapy: strontium kinetics and dosimetry in two patients treated for metastasising osteosarcoma. Br J Radiol. 1987;60:253–9.PubMedCrossRef
Metadata
Title
New knowledge about the bremsstrahlung image of strontium-89 with the scintillation camera
Authors
Hiroto Narita
Kiyoshi Hirase
Mayuki Uchiyama
Masahiro Fukushi
Publication date
01-08-2012
Publisher
Springer Japan
Published in
Annals of Nuclear Medicine / Issue 7/2012
Print ISSN: 0914-7187
Electronic ISSN: 1864-6433
DOI
https://doi.org/10.1007/s12149-012-0615-2

Other articles of this Issue 7/2012

Annals of Nuclear Medicine 7/2012 Go to the issue